New innovations in the clinico-molecular analysis of drug safety data
- At: 2017 FIP Congress in Stockholm (Sweden)
- Type: Presentation
- By: JACKSON, David (Molecular Health GmbH, Heidelberg, Germany)
- Co-author(s): David Jackson: Innovation, Molecular Health GmbH, Heidelberg, Germany
Efforts to decipher the mechanisms controlling genotype to phenotype transition are critical to medical advancements, yet we still rely heavily on insights from model organisms. While the new high-throughput molecular technologies are providing insights directly from patients, progress is hindered by cost and privacy concerns. To complement.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.